If you're looking for MS care in Louisiana, you can compare services across centers from New Orleans-area systems like Ochsner and LSU Health to regional clinics such as The NeuroMedical Center and Neuro Medical Clinic of Cenla. Use regional differences, provider availability, and clinic reputation to decide which center feels like the best fit for your ongoing MS care.
5 MS treatment centers4 active clinical trialsTop centers include The NeuroMedical Center and Ochsner LSU Health2 providers with Medicare prescribing data
Center types in Louisiana
Community Hospital Program (2)
Academic MS Center (1)
Dedicated MS Practice (1)
Regional Neurology Group (1)
Filter by type:
40% of MS centers in Louisiana are classified as Community Hospital Program facilities.
Centers with Most Active Trials in Louisiana
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
1. The NeuroMedical Center4 trials
Largest Care Teams in Louisiana
1. The NeuroMedical Center2 providers
MS Care by City
Active MS clinical trials in Louisiana
See all 12 MS trials in Louisiana →ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
New Orleans
ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Alexandria
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Alexandria · New Orleans · +1
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Alexandria · Baton Rouge
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Baton Rouge · Shreveport
ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Alexandria
ActivePhase 3
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
Baton Rouge · New Orleans
Active
MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience
Ad scientiam
New Orleans





